Nektar Therapeutics
NKTR
#6523
Rank
S$0.93 B
Marketcap
S$46.03
Share price
-3.99%
Change (1 day)
190.89%
Change (1 year)

EPS for Nektar Therapeutics (NKTR)

EPS in 2025 (TTM): S-$10.39

According to Nektar Therapeutics 's latest financial reports the company's current EPS (TTM) is S-$10.15. In 2024 the company made an earnings per share (EPS) of S-$11.29 an increase over its 2023 EPS that were of S-$27.89.

EPS history for Nektar Therapeutics from 2012 to 2025

Annual EPS

Year EPS Change
2025 (TTM)S-$10.39-7.97%
2024S-$11.29-59.54%
2023S-$27.89-25.89%
2022S-$37.64-31.12%
2021S-$54.6414.86%
2020S-$47.57-1.19%
2019S-$48.15-163.96%
2018S$75.28-725.4%
2017S-$12.04-42.73%
2016S-$21.0283.33%
2015S-$11.4639.53%
2014S-$8.22-69.29%
2013S-$26.75-6.67%
2012S-$28.66

EPS for similar companies or competitors

Company EPS EPS differencediff. Country
Johnson & Johnson
JNJ
S$13.30-230.98%๐Ÿ‡บ๐Ÿ‡ธ USA
Pfizer
PFE
S$2.19-121.58%๐Ÿ‡บ๐Ÿ‡ธ USA
Amgen
AMGN
S$16.60-263.49%๐Ÿ‡บ๐Ÿ‡ธ USA
Baxter
BAX
S-$0.84-91.72%๐Ÿ‡บ๐Ÿ‡ธ USA
Merck
MRK
S$9.67-195.28%๐Ÿ‡บ๐Ÿ‡ธ USA
AstraZeneca
AZN
S$6.81-167.13%๐Ÿ‡ฌ๐Ÿ‡ง UK
Richardson Electronics
RELL
S$0.08916-100.88%๐Ÿ‡บ๐Ÿ‡ธ USA
Alkermes
ALKS
S$2.64-125.97%๐Ÿ‡ฎ๐Ÿ‡ช Ireland